Navigation Links
Micell Technologies Reports Preclinical Data for MiStent™ Drug-Eluting Coronary Stent to be Presented at EuroPCR
Date:5/11/2011

DURHAM, N.C., May 11, 2011 /PRNewswire/ -- Micell Technologies, Inc. today announced that positive preclinical data will be presented at the EuroPCR conference in Paris, France on May 18, 2011 in a presentation titled, "MiStent DES: A Novel Third Generation DES with a Fully-absorbable Coating and Enhanced Drug Delivery Capabilities." The MiStent Drug-Eluting Coronary Stent System ("MiStent DES") is an ultra-thin, advanced alloy drug-eluting stent distinguished by a rapid-absorbing drug/polymer coating formulation.

In a porcine coronary model, data show continuous and controlled release of sirolimus, with the MiStent DES coating being eliminated from the stent within 45 to 60 days, and fully absorbed in the tissue by 90 days following implant. Preclinical studies additionally demonstrated a positive indication of safety with lower inflammation observed from the MiStent DES compared to the bare metal Abbott MULTI-LINK Vision™ Coronary Stent at 30 and 90 days in the challenging overlapping stents implant configuration.

James B. McClain, Ph.D., Senior Vice President of Micell, said, "Micell is uniting well-known DES stent components with a proprietary coating process to produce a fundamentally different DES. Our preclinical studies demonstrate a markedly consistent drug delivery profile with controlled, linear release of therapeutic levels of drug."

Clinical trials of the MiStent DES include DESSOLVE I, a study of 30 patients with documented stable or unstable angina pectoris or ischemia, which completed enrollment earlier this year. The primary endpoint is in-stent late lumen loss, as measured with angiography in treated de novo lesions ranging in diameter from 2.5 to 3.5 mm and amenable to treatment with a maximum 23 mm long stent. DESSOLVE II is an ongoing multi-center study of approximately 270 patients with documented stable or unstable angina pectoris or ischemia. The primary endpoint is superiority of MiStent DES in minimiz
'/>"/>

SOURCE Micell Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Micell Technologies Rapid Absorption Polymer DES System to be Presented at CRT 2009
2. Micell Forges Strategic Agreement to Develop Advanced Drug-Eluting Stents and Balloons
3. The Micell Rapid Absorption Polymer DES System to be Presented at TCT 2008
4. Terumo Americas Holding, Inc., Agrees to Acquire Harvest Technologies Corporation, a Leader in the Development of Point-of-Care Cellular Therapy
5. BioSpecifics Technologies Corp. Reports First Quarter 2011 Financial Results
6. Netsmart Technologies Names Michael Valentine as Chief Executive Officer
7. Caliper Owners Group and Investor Meeting to Highlight Technologies Enabling Personalized Medicine
8. Reportlinker Adds Biomarkers: Technologies and Global Markets
9. Reportlinker Adds Medical Enzymes: Technologies and Global Markets
10. Life Technologies Names Dr. Ora Hirsch Pescovitz to its Board of Directors
11. China Green Material Technologies, Inc. Announces Change of Auditor to Marcum Bernstein & Pinchuk LLP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... May 16, 2013 ISPE ... A. Myers, CAE, to the newly created position ... new role, Myers will be responsible for stimulating ... production strategies, advancing the Society’s Member-led and staff-driven ... continuing to refine organizational, membership and product marketing. ...
(Date:5/16/2013)... A new selection of laboratory ... is designed to meet the dynamic needs of ... new Cole-Parmer® MS-3400 Centrifuges are clinical ... They ensure a powerful and complete separation of ... standard four-place swinging buckets hold 50-mL tubes. With ...
(Date:5/16/2013)... , May 16, 2013  HealthSparq, a ... of the nation,s largest regional health plans, will ... Health Insurance Plans (AHIP) Institute 2013 conference on ... survey results showing how health insurance companies across ... the consumer and marketplace demands for increased healthcare ...
(Date:5/16/2013)... 2013 As the weather warms, women everywhere ... Spring looks. While most make a statement with fashion, many ... find the warmer weather mixes makeup and sweat to produce, ... onset of acne during warmer months, Adult Acne treatment ... users the best ways to deter breakouts. , Recently, ...
Breaking Biology Technology:ISPE Names Barbara A. Myers, CAE, as Vice President of Professional Development 2Cole-Parmer Offers Enhanced Selection of Centrifuges 2HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 2HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 3Adult Acne Treatment, Probiotic Action Shares New Tips for Women on How to Fight Acne While Wearing Makeup 2
... LIVINGSTON, N.J., May 27 Milestone Scientific,Inc. (OTC Bulletin ... announced that it will host its 2008 Annual,Meeting of ... AM,Eastern Time at the law offices of Brown, Rudnick, ... York City., Shareholders of record as of the ...
... Wash., May 27 CellCyte Genetics,Corporation (CellCyte) ... to provide shareholders, potential investors and journalists,with ... comprehensive,Investor Room powered Web site: http://www.cellcyte.com ... information or sources for stories from,CellCyte can ...
... 26 Inverness Medical,Innovations, Inc. (Amex: IMA ... products for the consumer and professional markets, announced,today ... Markets 12th Annual,Spring Investor Conference being held May ... Ron Geraty, President, Health Management, and Jon Russell, ...
Cached Biology Technology:Milestone Scientific to Host 2008 Annual Meeting of Stockholders on Thursday, June 5, 2008 in New York City 2Inverness Medical Innovations to Present at FBR Capital Markets 12th Annual Spring Investor Conference on May 28, 2008 2
(Date:5/16/2013)... BOSTON The endothelium, the cellular layer lining ... just a few hundred nanometers in thickness, this ... stretch and tissue compression to create a unique ... necessary to partition tissues from the body,s circulatory ... when the barrier must be physically breached ...
(Date:5/16/2013)... SPARTANBURG, S.C. , May 16, 2013 /PRNewswire/ ... film in combination with a custom thin film ...  the highest forensic quality roll image in the ... market today. Sherlock, an Appendix F Mobile ID ... provides a 95% reduction in size and weight ...
(Date:5/16/2013)... hematopoiesis at sites outside the bone marrow in ... (LMU) in Munich now show that a specific type ... blood cells. , Balanced hematopoiesis is essential for the ... takes place mainly in the liver and the spleen. ... and this tissue normally serves as the sole source ...
Breaking Biology News(10 mins):Endothelium, heal thyself 2Endothelium, heal thyself 3Endothelium, heal thyself 4Herpes infections: Natural killer cells activate hematopoiesis 2
... A new study on human impact to wildlife in some ... which trails can be used before ecological disturbance takes place. ... Kimo Rogala, is published in the current online issue of ... professor Marco Musiani in the Faculty of Environmental Design. ...
... today announced that Prof. Madhav Marathe has been selected ... The George A. Michael Distinguished Scholar is an annual ... significant time carrying out research at the Institute for ... The intent of the scholarship is to foster long-term ...
... study supported by the U.S. Department of Health and Human ... suggested the presence of one of several viruses in blood ... study also could not find the viruses in blood samples ... the viruses., The HHS-supported study examined the validity of testing ...
Cached Biology News:Limits for mountain trail use identified 2XMRV, related viruses not confirmed in blood of healthy donors or chronic fatigue syndrome patients 2XMRV, related viruses not confirmed in blood of healthy donors or chronic fatigue syndrome patients 3XMRV, related viruses not confirmed in blood of healthy donors or chronic fatigue syndrome patients 4
... stability and convenience from the former kit #17295. ... this problem but also produced some advantages as ... of HRP conjugated antibody from lyophilized product to ... stability of the conjugate has improved so that ...
... multi-purpose, high gel-strength agarose suitable for a ... conventional constant field to Pulsed Field Gel ... strength and exclusion limits, Multi ABgarose can ... running times. This in turn means reduced ...
... The IDS EIA kit is a complete ... Vitamin D (1,25D) in human serum or ... immunoextraction system found in the IDS 1,25D ... The assay comes with ready to use ...
... is a molecular screening, low melting point ... sieving. It is recommended for separation of ... such as PCR products. Micro ABgarose is ... not recommended for blotting techniques. At a ...
Biology Products: